These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 6800419)
1. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. Fass DN; Knutson GJ; Katzmann JA Blood; 1982 Mar; 59(3):594-600. PubMed ID: 6800419 [TBL] [Abstract][Full Text] [Related]
2. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. Weinstein MJ; Chute LE J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875 [TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage. Precup JW; Kline BC; Fass DN Blood; 1991 May; 77(9):1929-36. PubMed ID: 1902121 [TBL] [Abstract][Full Text] [Related]
5. The use of monoclonal antibodies in measuring factor VIII/von Willebrand factor. Lamme S; Wallmark A; Holmberg L; Nilsson IM; Sjögren HO Scand J Clin Lab Invest; 1985 Feb; 45(1):17-26. PubMed ID: 3919440 [TBL] [Abstract][Full Text] [Related]
6. Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII. Croissant MP; van de Pol H; Lee HH; Allain JP Thromb Haemost; 1986 Dec; 56(3):271-6. PubMed ID: 2436329 [TBL] [Abstract][Full Text] [Related]
7. The separation of Willebrand factor from factor VIII-related antigen. Barrow ES; Reisner HM; Graham JB Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303 [TBL] [Abstract][Full Text] [Related]
8. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896 [TBL] [Abstract][Full Text] [Related]
9. Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor. Shima M; Yoshioka A; Nakai H; Tanaka I; Sawamoto Y; Kamisue S; Terada S; Fukui H Int J Hematol; 1991 Dec; 54(6):515-22. PubMed ID: 1724391 [TBL] [Abstract][Full Text] [Related]
10. Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF). Nilsson IM Semin Hematol; 1988 Apr; 25(2 Suppl 1):33-7. PubMed ID: 3133776 [No Abstract] [Full Text] [Related]
11. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen. Benson RE; Johnson GS; Dodds WJ Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients. Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities. Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P Proc Natl Acad Sci U S A; 1982 Jan; 79(1):183-7. PubMed ID: 6798569 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of factor VIII 1,689-Cys: a nonfunctional cofactor occurring in a patient with severe hemophilia A. O'Brien DP; Tuddenham EG Blood; 1989 Jun; 73(8):2117-22. PubMed ID: 2499363 [TBL] [Abstract][Full Text] [Related]
15. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies]. Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762 [TBL] [Abstract][Full Text] [Related]
16. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339 [TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies against the factor VIII/Willebrand factor molecule: inhibition of the cofactor action of ristocetin and the antihemophilic factor]. Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P C R Seances Acad Sci III; 1981 May; 292(18):1055-7. PubMed ID: 6790137 [TBL] [Abstract][Full Text] [Related]
18. Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysis. Knutson GJ; Fass DN Blood; 1982 Mar; 59(3):615-24. PubMed ID: 6800420 [No Abstract] [Full Text] [Related]